Oversecretion and Overexpression of Nicotinamide Phosphoribosyltransferase/Pre-B Colony-Enhancing Factor/Visfatin in Inflammatory Bowel Disease Reflects the Disease Activity, Severity of Inflammatory Response and Hypoxia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oversecretion and Overexpression of Nicotinamide Phosphoribosyltransferase/Pre-B Colony-Enhancing Factor/Visfatin in Inflammatory Bowel Disease Reflects the Disease Activity, Severity of Inflammatory Response and Hypoxia
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 1, Pages 166
Publisher
MDPI AG
Online
2019-01-05
DOI
10.3390/ijms20010166
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nicotinamide phosphoribosyltransferase and the hypothalamic-pituitary-adrenal axis of the rat
- (2018) Piotr Celichowski et al. Molecular Medicine Reports
- Positive association between leptin serum levels and disease activity on endoscopy in inflammatory bowel disease: A case-control study
- (2018) Fabiola Trejo‑Vazquez et al. Experimental and Therapeutic Medicine
- The Epithelial-to-Mesenchymal Transition in Cancer
- (2018) Joëlle Roche Cancers
- Estrogen and progesterone dependent expression of visfatin/NAMPT regulates proliferation and apoptosis in mice uterus during estrous cycle
- (2018) Lalrawngbawli Annie et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Inflammatory Bowel Disease 2017: Innovations and Changing Paradigms
- (2017) Jean-Frederic Colombel et al. GASTROENTEROLOGY
- NAD metabolism fuels human and mouse intestinal inflammation
- (2017) Romana R Gerner et al. GUT
- NAD Synthesis Pathway Interference Is a Viable Therapeutic Strategy for Chondrosarcoma
- (2017) Elisabeth F.P. Peterse et al. MOLECULAR CANCER RESEARCH
- Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer
- (2017) Jair Machado Espindola-Netto et al. Oncotarget
- Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?
- (2017) Michael Camilleri et al. Expert Review of Gastroenterology & Hepatology
- NAMPT serum levels are selectively elevated in acute infectious disease and in acute relapse of chronic inflammatory diseases in children
- (2017) Julia Gesing et al. PLoS One
- Extracellular nicotinamide phosphoribosyltransferase, a new cancermetabokine
- (2016) Ambra A Grolla et al. BRITISH JOURNAL OF PHARMACOLOGY
- Epithelial-mesenchymal transition in tissue repair and fibrosis
- (2016) Rivka C. Stone et al. CELL AND TISSUE RESEARCH
- Chemerin, visfatin, and vaspin serum levels in relation to bone mineral density in patients with inflammatory bowel disease
- (2016) Sotirios Terzoudis et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Bowel Disorders
- (2016) Brian E. Lacy et al. GASTROENTEROLOGY
- Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn's disease from UC
- (2016) Amanda E Starr et al. GUT
- Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort
- (2016) Akbar K. Waljee et al. PLoS One
- Inflammatory bowel disease pathogenesis: Where are we?
- (2015) Claudio Fiocchi JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Physiological and pathophysiological roles of NAMPT and NAD metabolism
- (2015) Antje Garten et al. Nature Reviews Endocrinology
- The epidemiology of inflammatory bowel disease
- (2015) Johan Burisch et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Extensive regulation of nicotinate phosphoribosyltransferase (NAPRT) expression in human tissues and tumors
- (2015) Sara Duarte-Pereira et al. Oncotarget
- Nampt/PBEF/Visfatin Upregulation in Colorectal Tumors, Mirrored in Normal Tissue and Whole Blood of Colorectal Cancer Patients, Is Associated with Metastasis, Hypoxia, IL1β, and Anemia
- (2015) Katarzyna Neubauer et al. Biomed Research International
- Expression Stability of Common Housekeeping Genes Is Differently Affected by Bowel Inflammation and Cancer
- (2014) Malgorzata Krzystek-Korpacka et al. INFLAMMATORY BOWEL DISEASES
- Adipokines NUCB2/Nesfatin-1 and Visfatin as Novel Inflammatory Factors in Chronic Obstructive Pulmonary Disease
- (2014) Sirpa Leivo-Korpela et al. MEDIATORS OF INFLAMMATION
- Serum adipokines in inflammatory bowel disease
- (2014) Marek Waluga WORLD JOURNAL OF GASTROENTEROLOGY
- Nampt secreted from cardiomyocytes promotes development of cardiac hypertrophy and adverse ventricular remodeling
- (2012) Vinodkumar B. Pillai et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Mucosal healing in inflammatory bowel diseases: a systematic review
- (2012) Markus F Neurath et al. GUT
- Results of the 2nd part Scientific Workshop of the ECCO (II): Measures and markers of prediction to achieve, detect, and monitor intestinal healing in Inflammatory Bowel Disease
- (2011) Marco Daperno et al. Journal of Crohns & Colitis
- Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets
- (2010) Bertalan Mesko et al. BMC Medical Genomics
- Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease
- (2009) Alexander R. Moschen et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Estrogens induce visfatin expression in 3T3-L1 cells
- (2009) Jingyu Zhou et al. PEPTIDES
- Upregulation of fibroblast growth factor-2 by visfatin that promotes endothelial angiogenesis
- (2008) Yun-Hee Bae et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease
- (2008) Luzia Valentini et al. NUTRITION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started